ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    The Impact of Thrombin / Protease-Activated Receptor-1 Pathway in Hepatic Ischemia-Reperfusion Injury in Mice

    D. Noguchi, N. Kuriyama, T. Fujii, H. Kato, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji

    Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, Japan

    *Purpose: Coagulation cascade is an important pathway in the pathophysiology of hepatic ischemia-reperfusion injury(IRI). Generation of thrombin is a critical factor of coagulation induced by…
  • 2019 American Transplant Congress

    Increased Ratio of Circulating Tfh for Tfr Cells in Chronic Renal Allograft Dysfunction: A Pilot Study

    L. Yan, Y. Li, Y. Li, X. Wu, X. Wang, L. Wang, Y. Shi, J. Tang

    West China Hospital OF Sichuan University, Chengdu, China

    *Purpose: T follicular helper (Tfh) cells play a central role in contribution of B cell differentiation and antibody production. T follicular regulatory (Tfr) cells inhibit…
  • 2019 American Transplant Congress

    Contribution of CD38 to Methionine Choline Deficient (MCD) Diet-Induced Liver Injury in Rats

    J. Kim, Y. Lee, B. F. Reader, C. Akateh, K. R. Maynard, K. W. Washburn, J. L. Zweier, B. A. Whitson, S. M. Black

    Department of Cardiac Surgery, The Ohio State Univ. Medical Center, Columbus, OH

    *Purpose: Nonalcoholic fatty liver disease (NAFLD) and associated non-alcoholic steatohepatitis (NASH) is a rising cause of end stage liver disease, increasing the need for liver…
  • 2019 American Transplant Congress

    Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naïve Hepatocellular Carinoma Patients

    K. Nunez, T. Sandow, S. Robertson, P. Thevenot, A. Cohen

    Ochsner Health System, New Orleans, LA

    *Purpose: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related deaths in the world with recurrence rates at 40%. Locoregional therapy (LRT) is standard…
  • 2019 American Transplant Congress

    Unfair Waiting Time Calculation? Impact of Accumulated Wait Time Restart with a Decrease in Status from 1A to 1B or 2 on Mortality of Heart Transplant Candidates

    S. Yu, M. Kosztowski, M. Waldram, D. L. Segev, A. B. Massie

    Department of Surgery, Johns Hopkins, Baltimore, MD

    *Purpose: Between two heart transplant (HT) candidates listed at the same status, the candidate with longer accumulated wait time receives higher waitlist priority; under current…
  • 2019 American Transplant Congress

    The Use Of First-year Intravascular Ultrasound In The Tacrolimus Era In Heart Transplantation

    S. Dimbil1, M. Kittleson1, J. Patel1, D. Geft1, R. Cheng1, R. Levine1, T. Sato1, L. Czer1, R. Zabner2, P. Zakowski2, J. A. Kobashigawa1, B. Azarbal1

    1Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, 2Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: Cytomegalovirus (CMV) has been documented as a risk factor for the development of cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). It has not…
  • 2019 American Transplant Congress

    No Plan is a Bad Plan! Results of the American Society of Transplantation (AST) Living Donor Community of Practice Mortality Workgroup Survey on Disaster Planning Following a Living Donor Death

    M. L. Henderson1, S. E. Van Pilsum Rasmussen1, M. M. Waldram1, K. L. Lentine2, D. A. Mandelbrot3, R. L. Hays3, D. G. Maluf4, M. Cooper5

    1Johns Hopkins, Baltimore, MD, 2Saint Louis University, St Louis, MO, 3University of Wisconsin, Madison, WI, 4University of Tennessee, Memphis, TN, 5Georgetown University, Washington, DC

    *Purpose: The risk of perioperative mortality following living kidney and liver donation, although extremely low, must not be considered a ‘never event’. While the risks…
  • 2019 American Transplant Congress

    The Association of Kidney Transplant Center Volume with 3-Year Outcomes

    E. M. Sonnenberg1, J. B. Cohen2, J. Y. Hsu3, V. S. Potluri2, M. H. Levine1, P. L. Abt1, P. P. Reese2

    1Surgery, University of Pennsylvania, Philadelphia, PA, 2Renal Division, University of Pennsylvania, Philadelphia, PA, 3Biostatistics, University of Pennsylvania, Philadelphia, PA

    *Purpose: To assess if a center volume-outcome relationship exists for contemporary kidney transplantation, specifically in increased-risk scenarios including: diabetic recipients, elderly recipients (age>65) or recipients…
  • 2019 American Transplant Congress

    The Implications of Donor Proteinuria in Deceased Donor Kidney Transplantation

    A. Vinson, T. Keough-Ryan, K. West, K. Tennankore

    Dalhousie University, Halifax, NS, Canada

    *Purpose: The implications of pre-terminal donor urinalysis findings on post-transplant kidney graft survival has not been previously explored. An abnormal donor urinalysis may reflect donor…
  • 2019 American Transplant Congress

    Reduction of Circulating DSA: Does It Affect Histology?

    M. Gupta1, E. Edusei1, S. Tsai2, M. Magruder2, J. Lee1, J. Lee1, C. Hartono1, T. Muthukumar1, M. Everly3, D. Dadhania1

    1Nephrology, New York Presbyterian Weill Cornell, New York, NY, 2New York Presbyterian Weill Cornell, New York, NY, 3Terasaki Research Institute, Los Angeles, CA

    *Purpose: De novo donor specific antibodies (dnDSA) are reported in 13-30% of kidney transplant recipients. dnDSA has been associated with antibody mediated rejection (AMR) and…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences